To summarize the key developments and performance metrics of JAMA Dermatology in 2025.
Key Findings:
The impact factor remained high at 11.
The article on nicotinamide supplementation showed potential benefits for skin cancer prevention.
AI applications in dermatology were highlighted, including studies on wearable devices providing haptic feedback and risk stratification tools for cutaneous squamous cell carcinoma.
Interpretation:
The journal's focus on timely publication and high-quality research continues to enhance its relevance in dermatology.
Limitations:
The need for prospective randomized clinical trials to confirm findings on nicotinamide.
Potential overdiagnosis issues in melanoma screening were discussed, emphasizing the need for careful evaluation.
Conclusion:
JAMA Dermatology is committed to publishing impactful research that informs clinical practice while adapting to evolving challenges in dermatology.
